The following table contains 19 products whose active ingredient are classified under the same pharmacologic class Vascular Endothelial Growth Factor Inhibitors [MoA].
|
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Status |
| 0024-5840 | Zaltrap | Non-Proprietary Name: Ziv-aflibercept | Solution, Concentrate | Intravenous | Sanofi-aventis U.s. Llc | ACTIVE |
| 0024-5841 | Zaltrap | Non-Proprietary Name: Ziv-aflibercept | Solution, Concentrate | Intravenous | Sanofi-aventis U.s. Llc | ACTIVE |
| 0069-0315 | Zirabev | Non-Proprietary Name: Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE |
| 0069-0342 | Zirabev | Non-Proprietary Name: Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE |
| 50242-060 | Avastin | Non-Proprietary Name: Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE |
| 50242-061 | Avastin | Non-Proprietary Name: Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE |
| 50242-078 | Susvimo | Non-Proprietary Name: Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE |
| 50242-080 | Lucentis | Non-Proprietary Name: Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE |
| 50242-082 | Lucentis | Non-Proprietary Name: Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE |
| 55513-206 | Mvasi | Non-Proprietary Name: Bevacizumab-awwb | Injection, Solution | Intravenous | Amgen Inc | ACTIVE |
| 55513-207 | Mvasi | Non-Proprietary Name: Bevacizumab-awwb | Injection, Solution | Intravenous | Amgen Inc | ACTIVE |
| 61755-005 | Eylea | Non-Proprietary Name: Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc. | ACTIVE |
| 64406-019 | Byooviz | Non-Proprietary Name: Ranibizumab-nuna | Injection, Solution | Intravitreal | Biogen Inc. | ACTIVE |
| 70114-440 | Cimerli | Non-Proprietary Name: Ranibizumab-eqrn | Injection, Solution | Intravitreal | Coherus Biosciences Inc | ACTIVE |
| 70114-441 | Cimerli | Non-Proprietary Name: Ranibizumab-eqrn | Injection, Solution | Intravitreal | Coherus Biosciences Inc | ACTIVE |
| 70121-1754 | Alymsys | Non-Proprietary Name: Bevacizumab-maly | Injection, Solution | Intravenous | Amneal Pharmaceuticals Llc | ACTIVE |
| 70121-1755 | Alymsys | Non-Proprietary Name: Bevacizumab-maly | Injection, Solution | Intravenous | Amneal Pharmaceuticals Llc | ACTIVE |
| 72606-011 | Vegzelma | Non-Proprietary Name: Bevacizumab-adcd | Injection, Solution | Intravenous | Cellrion Usa, Inc. | ACTIVE |
| 72606-012 | Vegzelma | Non-Proprietary Name: Bevacizumab-adcd | Injection, Solution | Intravenous | Cellrion Usa, Inc. | ACTIVE |